Moderna stock soared early in the pandemic thanks to sales of its coronavirus vaccine. After soaring to success in the early ...

Interest in what caused the coronavirus pandemic has many political dimensions today, with President Trump saying genetic ...

The American College of Obstetricians and Gynecologists is urging insurers to continue covering vaccinations during pregnancy in an open letter signed by 30 prominent professional health organizations ...

The Trump administration had said it would disclose by Wednesday the target prices for drugs, but pharma companies are still ...

US Health Secretary Robert F. Kennedy Jr.'s dismissal of a key panel that advises on immunizations policy is a significant ...

Novavax NVAX announced encouraging results from an initial cohort of a late-stage study evaluating its experimental ...

BioNTech said Thursday it has agreed to acquire smaller biotech CureVac in a $1.25 billion all-stock deal in another push to ...

His latest action confirms his intention to delist specific vaccines, making them less affordable.

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...